Autologous hematopoietic stem cell transplant for the treatment of refractory myasthenia gravis with <scp>anti‐muscle</scp> specific kinase antibodies
Benjamin Béland(University of Calgary), Jan Storek(University of Washington), Kareem Jamani(Fred Hutch Cancer Center), Chris White(University of Calgary), Sameer Chhibber(University of Calgary), Christopher Hahn(University of Pennsylvania), Harold Atkins(University of Ottawa)
Cited by 10
Related Papers
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
|Cancer Cell|2003|850
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
|Nature Medicine|2000|816
Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia
|Nature Genetics|2011|604
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
|New England Journal of Medicine|2018|598
A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)
|Journal of Computer Assisted Tomography|1980|503